Minerva Surgical Inc
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally… Read more
Minerva Surgical Inc (UTRS) - Net Assets
Latest net assets as of September 2023: $20.25 Million USD
Based on the latest financial reports, Minerva Surgical Inc (UTRS) has net assets worth $20.25 Million USD as of September 2023.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($72.78 Million) and total liabilities ($52.53 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $20.25 Million |
| % of Total Assets | 27.83% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Minerva Surgical Inc - Net Assets Trend (2019–2022)
This chart illustrates how Minerva Surgical Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Minerva Surgical Inc (2019–2022)
The table below shows the annual net assets of Minerva Surgical Inc from 2019 to 2022.
| Year | Net Assets | Change |
|---|---|---|
| 2022-12-31 | $17.18 Million | -61.04% |
| 2021-12-31 | $44.10 Million | +119.88% |
| 2020-12-31 | $-221.81 Million | -8.45% |
| 2019-12-31 | $-204.52 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Minerva Surgical Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7383900000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2022)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $29.00K | 0.17% |
| Other Comprehensive Income | $11.00K | 0.06% |
| Other Components | $300.81 Million | 1750.82% |
| Total Equity | $17.18 Million | 100.00% |
Minerva Surgical Inc Competitors by Market Cap
The table below lists competitors of Minerva Surgical Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Botswana Diamonds plc
LSE:BOD
|
$276.95 |
|
Bunnys Limited
KAR:BNL
|
$277.00 |
|
DANNEX AYRTON STARWIN PLC
GSE:DASPHARMA
|
$277.08 |
|
Securities Trust of Scotland plc
LSE:STS
|
$277.74 |
|
Crown Asia Chemicals Corp
PSE:CROWN
|
$276.56 |
|
NAMIBIAN COPPER
BE:42N
|
$275.80 |
|
One Health Group Plc
LSE:OHGR
|
$275.73 |
|
Beacon Rise Holdings PLC
LSE:BRS
|
$274.78 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Minerva Surgical Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2021 to 2022, total equity changed from 44,104,000 to 17,181,000, a change of -26,923,000 (-61.0%).
- Net loss of 34,112,000 reduced equity.
- New share issuances of 36,000 increased equity.
- Other factors increased equity by 7,153,000.
Equity Change Factors (2021 to 2022)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-34.11 Million | -198.54% |
| Share Issuances | $36.00K | +0.21% |
| Other Changes | $7.15 Million | +41.63% |
| Total Change | $- | -61.04% |
Book Value vs Market Value Analysis
This analysis compares Minerva Surgical Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2019-12-31 | $-220.62 | $0.00 | x |
| 2020-12-31 | $-217.47 | $0.00 | x |
| 2021-12-31 | $30.79 | $0.00 | x |
| 2022-12-31 | $11.93 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Minerva Surgical Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -198.54%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -67.83%
- • Asset Turnover: 0.73x
- • Equity Multiplier: 4.01x
- Recent ROE (-198.54%) is below the historical average (-61.80%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2019 | 0.00% | -200.08% | 0.56x | 0.00x | $-31.59 Million |
| 2020 | 0.00% | -48.36% | 0.41x | 0.00x | $3.92 Million |
| 2021 | -48.67% | -41.20% | 0.45x | 2.61x | $-25.87 Million |
| 2022 | -198.54% | -67.83% | 0.73x | 4.01x | $-35.83 Million |
Industry Comparison
This section compares Minerva Surgical Inc's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $694,749,556
- Average return on equity (ROE) among peers: -25.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Minerva Surgical Inc (UTRS) | $20.25 Million | 0.00% | 2.59x | $276.91 |
| Advanced Biomedical Technologies Inc (ABMT) | $-4.46 Million | 0.00% | 0.00x | $14.18K |
| Abbott Laboratories (ABT) | $4.82 Billion | 39.04% | 1.31x | $191.37 Billion |
| Acarix AB (publ) (ACIXF) | $1.93 Million | -127.02% | 0.21x | $26.42 Million |
| Adagio Medical Holdings, Inc Common Stock (ADGM) | $-72.62 Million | 0.00% | 0.00x | $4.05 Million |
| Adm Tronics Unltd (ADMT) | $-12.69K | 0.00% | 0.00x | $3.17 Million |
| Aethlon Medical Inc (AEMD) | $-3.07 Million | 0.00% | 0.00x | $2.79 Million |
| Acutus Medical Inc (AFIB) | $126.58 Million | -80.56% | 0.52x | $732.88K |
| Adapthealth Corp (AHCO) | $2.07 Billion | 7.56% | 1.54x | $914.25 Million |
| Allied Healthcare Products Inc. (AHPIQ) | $8.88 Million | -33.95% | 1.22x | $726.24 |
| 20/20 Biolabs, Inc. Common Stock (AIDX) | $3.39 Million | -59.65% | 0.38x | $9.18 Million |